http://dx.doi.org/10.18081/jcc/016-06/1-8
Journal of Cellular Cancer  Volume 8, Issue 1, pages 1-8
Received December 23, 2015; accepted May 12, 2016; published June 11, 2016

Estabraq AR. Al-Wasiti*

Abstract

Male breast cancer is a rare compared to its female counterpart and makes less than 1% of all breast cancer. Risk factors for breast cancer in men, including genetic, hormonal and environmental factors, provide parallels to the etiology of breast cancer in women. To evaluate whether deficient DNA repair contributes to elevated DNA damage and breast carcinogenesis, this study used comet assay (single-cell alkaline gel electrophoresis) to measure the levels of DNA damage in peripheral leukocytes and tissue from 20 breast tumor cases and 20 controls (only peripheral leukocytes). The results showed that cancer cases had significant higher DNA damage compared with controls and benign cases, the comet tail moments (mean ±SD) for cases (benign and cancer) and controls were: 5.64±0.88, 7.93±0.82 and 3.18±0.74 respectively. For tissue the cancer cases showed higher DNA damage compared with begin breast tumors (15.33±0.92 and 11.24± 1.57). Smoking status was causes to increase DNA damage in the Leukocyte of the patients with benign breast tumors and breast cancer when compared to non smoking cases the (mean ±SD) for benign (5.17±0.71 versus 6.47±0.41) while for malignant tumors were (7.25±0.62 versus 8.0±0.39). As body mass index (BMI) increase will causes increases in DNA damage for benign and malignant breast tumor. In conclusion our results support the hypothesis that increased breast cancer risk is associated with higher DNA damage and evaluation of DNA damage response may contribute to early detection and prevention of breast cancer.

Keywords: Comet assay; Oxidative DNA damage; Male breast cancer

<

p style=”text-align: justify;”>

Article citationReferencesFull-Text/PDFFeedback
The citation data is computed by the crossref service:

citedby

References

  1. Martynowicz H, Medraś M, Andrzejak R. Occupational risk factors and male breast cancer. Medycyna Pracy 2005;56:405-10. [Abstract/Full-Text
  2. Lambley J, Maguire E, Lam KY. Synchronous bilateral breast cancer in an elderly man. Breast J 2005;11:153. [Abstract/Full-Text]
  3. Forloni F, Giovilli M, Pecis C, et al. Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 4 5-yearold male. J EndocrinolInvst 2001; 24:454-459. [PubMed]
  4. Volm MD, Talamonti MS, Thangavelu M, Gradisher WK. Pituitary adenoma and bilateral male breast cancer: an unusual association. J SurgOncol 1997;64:74-78. [Abstract/Full-Text]
  5. Olsson H, Alm P, Kristoffersson U, Landin-Olsson M. Hypophyseal  tumor and gynecomastia preceding bilateral breast cancer development in a man. Cancer1984;1974-1977.
  6. Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother 2007;8:93-202. [PubMed]
  7. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncol 2005;10:471-479. [PubMed]
  8. Narod SA, OffitK. Prevention and management of hereditary breast cancer. J Clin Oncol 2005;23:1656-1663. [Abstract/Full-Text]
  9. Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AFand Jacobs PA. Cancer incidence and mortality in men with Klinefelter syndrome: A Cohort study. J Natl Cancer Inst 2005;97:1204-1210. [PubMed]
  10. Calderon-Garciduenas L, Osnaya N, Rodriguez-Alcaraz A, Villareal-Calderon A. DNA damage in nasal respiratory epithelium from children exposed to urban pollution. Environ. Mol. Mutagen 1997;30:11-20. [PubMed]
  11. Andreoli C, Leopardi P, Crebelli R. Detection of DNA damage in human lymphocytes by alkaline single cell gel electrophoresis after exposure to benzene or benzene metabolites. Mutat. Res 1997;377:95-104. [PubMed]
  12. Vodicka P, Tvordik T, Osterman-Golkar S. An evaluation of styrene genotoxicity using several biomarkers in a 3-year follow-up study of hand-lamination workers. Mutat. Res 1999;445:205-224. [Abstract]
  13. Zhu CQ, Lam TH, Jiang CQ, et al. Lymphocyte DNA damage in cigarette factory workers measured by the Comet Assay. Mutat. Res 1999;444:1-6.
  14. Moller P, Knudsen LE, Loft S, Wallin H. The comet assay as a rapid test in biomonitoring occupational exposure to DNA-damaging agents and effect of confounding factors. Cancer Epidem. Biomar. Prev 2000;9:1005-1015. [PubMed]
  15. Nath N, Chari SN, Rathi AB. superoxide dismutase in diabetic polymorphonuclear leukocytes. Diabetes 1984;33:586-589.
  16. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91. [Abstract/Full-Text]
  17. Chuang CH, Hu ML. Use of whole blood directly for single-cell gel electrophoresis (comet) assay in vivo and white blood cells for in vitro assay. Mutat Res 2004;564:75-82. [PubMed]
  18. Hodgson NC, Button JH, Franceschi D, Moffat FL, Livingstone AS. Male breast cancer: is the incidence increasing? Ann Surg Oncol 2004;11:751-5. [PubMed]
  19. Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005;10:471-9. [PubMed]
  20. Joseph A, Mokbel K. Male breast cancer. Int J FertilWomens Med 2004;49:198-9. [PubMed]
  21. Weiss JR, Moysich KB, and Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:20-6. [PubMed]
  22. Yoney A,Kucuk A, Unsal M. Male breast cancer: A retrospective analysis. Cancer/Radiothérapie 2009;13:103-107. [PubMed]
  23. Bonassi S, Neri M, Lando C, et al. Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the Human Micro-Nucleus project. Mutat. Res 2003;543:155-166. [PubMed]
  24. Faust F, Kassie F, Knasmüller S, et al. The use of the alkaline comet assay with lymphocytes in human biomonitoring studies. Mutat. Res 2004;566:209-229. [PubMed]
  25. Smith TR, Miller MS, Lohman KK, Case LD, HuJ. DNA damage and breast cancer risk. Carcinogenesis 2003;24:883-889. [PubMed]
  26. DaiQ, ShuX-o, JinF, GaoY-T, RuanZ-X, Zheng W. Consumption of animal foods, cooking methods, and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev.2002;11:801-808. [PubMed]
  27. Kathryn M, Belinda C, Richard D. Male breast cancer: Progress, prognosis and future pathways. Asia-Pacific Journal of Clinical Oncology 2008;4:6-17. [Abstract/Full-Text]
  28. Lucena R, Allam M, Costabeber I, Villarejo M, Navajas R. Breast cancer risk factors:PCB congners. Eur. J. Cancer Prev 2001;10:117-119. [PubMed]
  29. Hu J, Smith T, Miller M, Lohman K, Case L. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ. Mol. Mutagen 2002;39:208-215. [PubMed]
  30. Colleu-Durel S, Guitton N, Nourgalieva K,et al. Alkaline single-cell gel electrophoresis (Comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur J Cancer2004;40:445-451. [PubMed]
  31. Hussen MM, McNulty H, Armstrong N, Johnston PG, Spence R, Barnett Y. Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients. Br J Cancer 2005;92:1524-1530. [PubMed]
  32. Sigurdson A, Hauptmann M, Alexander B,et al. DNA damage among thyroidcancer and multiple cancer cases, controls, and long-lived individuals. Mutat. Res 2005;586:173-188. [Abstract/Full-Text]
  33. Schabath M, Spitz M, Grossmann H, et al. Genetic instability in bladder cancer assessed by the comet assay. J. Natl. Cancer Inst 2003;95:540-547. [PubMed]
  34. Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996;56:287-293. [PubMed]
  35. Li D, Zhang W, Sahin AA, Hittelman WN. DNA adducts in normal tissue adjacent to breast cancer: a review. Cancer Detect. Prev 1999;23:454462. [PubMed]
  36. Li D1, Zhang W, Zhu J, et al. Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apuriniclyase in human breast cancer. Mol. Carcinogen 2001;31:214-223. [PubMed]
  37. Musarrat J, Arezina-Wilson J, Wani AA. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur. J. Cancer 1996;32A:1209-1214. [PubMed]
  38. Malins DC, Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 1991;51:5430-5432. [PubMed]
  39. Rundle A, Tang D, Hibshoosh H, et al. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 2000;21:1281-1289. [PubMed]
  40. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in human: an epidemiologic review. J.Natl.Cancer Int 2000;92:874-97. [PubMed]
  41. Benhamou S, Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat. Res 2000;462-58.
  42. Paul H, Raymond R, Chris J, et al. Application of single-cell gel electrophoresis (comet) assay for assessing level of DNA damage in canine and feline leukocytes. J.Nutr 2002;132:1598S-1603S. [PubMed]
  43. Alice S, Michael H, Bruce H, et al. DNA damage among thyroid cancer and multiple cancer cases, control, and long-lived individuals. Mutation Research 2005;586:173-188. [Abstract/Full-Text]
  44. Popanda O, Ebbeler R, Twardella D, et al. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys 2003;55; 1216-1225. [PubMed]
  45. Wu X, Zhao H, Wie Q, et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003;24:505-509. [Abstract/Full-Text]
  46. Udumudi A, Jaiswal M, Rajeswari N, et al. Risk assessment in cervical dysplasia patients by single cell gel electrophoresis assay: a study of DNA damage and repair. Mutat. Res 1998;412:195-205. [Abstract/Full-Text]
  47. Ülkü Ü, Tevfik Ş, Osman Y,Hasan B, Osman K, Ferit T, Nurşen B. Assessment of DNA Damage in PeripheralBlood Lymphocytes From Patients with Benign and Malignant Thyroid Disorders. Hacettepe University Journal of the Faculty of Pharmacy 2008;28:1-14.
  48. Iarmarcovai G. Sari-Minodier I. Chaspoul F. et al. Risk assessment of welders using analysis of eight metals by ICP-MS in blood and urine and DNA damage evaluation by the comet and micronucleus assays; influence of XRCC1 and XRCC3 polymorphisms.Mutagenesis 2005;20(6):425-432. [PubMed]
  49. Kristin L, Lockett M, Craig H, et al. DNA damage levels in prostate cancer cases and controls. Carcinogenesis 2006;27(6):1187-1193. [Abstract/Full-Text]
  50. Gorlewska-RobertsK, Green B, Fares M, Ambrosone CB, Kadlubar F. Carcinogen-DNA adducts in human breast epithelial cells. Environ. Mol. Mutagen 2002;39:184-192. [PubMed]

Download PDF

For any technique error please contact us

Thank you for visiting Journal of Cellular Cancer.  * = Required fields

    Your Name (required)

    Your Email (required)

    Subject

    Your Message